Stay updated on Elacestrant in ER+ Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.

Latest updates to the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2. No substantive changes to the study details or page layout are observed.SummaryDifference0.0%

- Check20 days agoChange DetectedPublication reference updated: EMERALD JCO 2022 article added with Erratum and older version removed. Page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page now shows a glossary toggle and new metadata fields such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', plus a 'No FEAR Act Data' item and a 'Revision: v3.4.0' note.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page reflects Revision: v3.3.4 and removes Revision: v3.3.3, indicating a minor document revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedExpanded the Locations section to include a comprehensive list of participating sites across numerous countries and U.S. states. This provides clearer visibility into where the study is conducted.SummaryDifference3%

- Check91 days agoChange DetectedThe page revision was updated from v3.3.1 to v3.3.2, with no changes to study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Elacestrant in ER+ Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.